Gunnveig Grødeland
Influenza vaccine that can be rapidly produced to counter an emerging pandemic threat.
Gunnveig Grødeland og Bjarne Bogen
Foto
UiO/Yngve Vogt
Influenza vaccine that can be rapidly produced to counter an emerging pandemic threat.
Gunnveig Grødeland og Bjarne Bogen
UiO/Yngve Vogt